Clinical Trial Update: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing montelukast to intranasal fluticasone for managing allergic rhinitis in children aged 2 to 5.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Intranasal Fluticasone Propionate (fluticasone propionate)
• Montelukast (Montelukast)

Snippet

Sponsor: Usama Azhar | Conditions: Allergic Rhinitis | Phase 4 | Status: UNKNOWN